Shifts in Funding Priorities and Vaccine Guidance Contribute to Safety Myths, Plus Reactions to Ruling in U.S. v. Skrmetti — The Monitor

This volume examines how the cancellation of contracts to develop a bird flu vaccine and unfounded claims by new vaccine advisors reflect persistent myths about the safety of mRNA technology. It also explores false claims linking COVID-19 vaccines to miscarriage and analyzes how reactions to a Supreme Court ruling on gender-affirming care for minors highlights…

Read More

The GOP’s Budget Plan Is a Crisis in the Making for Hospitals

If enacted, the GOP’s spending bill would kick more than 10 million Americans off Medicaid. Experts are worried about the major spike in uncompensated care that hospitals would have to provide — and they’re warning that this change will result in major revenue losses for hospitals, facility closures, higher premiums for commercially insured patients, and…

Read More

The Discipline of Differentiation: Winning Strategies in a Crowded Cell and Gene Therapy Market

The cell and gene therapy sector has hit incredible milestones in recent years. As the sector continues to evolve and the climate becomes increasingly crowded and volatile, leaders must remain flexible in constantly refining the pipeline.  The post The Discipline of Differentiation: Winning Strategies in a Crowded Cell and Gene Therapy Market appeared first on…

Read More